Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» SAGE Therapeutics
SAGE Therapeutics
5 Biotech Buyout Candidates for 2018
Yahoo/Motley Fool
Wed, 12/13/17 - 09:36 am
biotech
M&A
Biogen
Biomarin
Bluebird Bio
Geron
SAGE Therapeutics
Sage Shares Soar Again As Depression Drug Hits Mark in Phase 2 Test
Xconomy
Thu, 12/7/17 - 09:18 am
SAGE Therapeutics
major depressive disorder
SAGE-217
3 Biotech Stocks That Soared This Week
Motley Fool
Sun, 11/12/17 - 10:32 am
biotech
Nektar
earnings
SAGE Therapeutics
brexanolone
postpartum depression
Valeant Pharmaceuticals
Sage Bounces Back, Eyes FDA Filing for Postpartum Drug
Xconomy
Thu, 11/9/17 - 10:04 am
SAGE Therapeutics
postpartum depression
brexanolone
FDA
clinical trials
The new Biotech Scorecard: 10 make-or-break industry events for the fourth quarter
Stat
Tue, 10/3/17 - 11:50 am
biotech
Axovant Sciences
intepirdine
SAGE Therapeutics
brexanolone
AbbVie
risankizumab
Global Blood Therapeutics
GBT-440
DBV Technologies
Viaskin Peanut
Cytokinetics
Amicus Therapeutics
ATB200
Spark Therapeutics
Bluebird Bio
Revance Therapeutics
RT002
Sage’s epilepsy drug fails to do better than placebo in key clinical trial
Stat
Tue, 09/12/17 - 10:01 am
SAGE Therapeutics
epilepsy
clinical trials
brexanolone
Sage Therapeutics reports 4Q loss
Yahoo/AP
Thu, 02/23/17 - 09:14 am
SAGE Therapeutics
earnings
Sage Therapeutics Leads Biotech Movers on False Takeout Rumors
TheStreet.com
Fri, 02/17/17 - 11:04 am
SAGE Therapeutics
M&A
Can Sage Therapeutics Press Even Further With Its Depression Trial?
Yahoo/24-7 Wall St
Mon, 02/13/17 - 03:32 pm
SAGE Therapeutics
major depressive disorder
SAGE-217
The FDA just signed off on a Formula 1 pivotal track for Sage’s postpartum depression drug
Endpoints
Tue, 12/6/16 - 09:46 am
FDA
SAGE Therapeutics
postpartum depression
SAGE-547
Sage Therapeutics shares surge 45% on positive trial of postpartum depression drug
Marketwatch
Tue, 07/12/16 - 11:15 am
SAGE Therapeutics
SAGE-547
postpartum depression
Sage Therapeutics, Inc: Overhyped Lead Drug Headed For Failure
Seeking Alpha
Wed, 03/23/16 - 09:43 pm
SAGE Therapeutics
SAGE-547
super-refractory status epilepticus
SRSE
Sage Therapeutics reports 4Q loss
Yahoo/AP
Wed, 02/24/16 - 10:54 am
SAGE Therapeutics
earnings
Sage Psychiatric Drug Shows Activity Hint in Small Muscle Tremor Study
TheStreet.com
Thu, 09/3/15 - 06:32 pm
SAGE Therapeutics
SAGE-547
essential tremors
Sage Therapeutics reports 2Q loss
Yahoo/AP
Wed, 08/12/15 - 09:08 am
SAGE Therapeutics
earnings
Sage gets a peek at success treating postpartum depression, and its shares soar
Fierce Biotech
Tue, 06/9/15 - 09:38 am
SAGE Therapeutics
postpartum depression
SAGE-547
What You Need To Know In Biotech: An ASCO Disappointment, Big Money In Brains And A New CF Drug
Forbes
Sun, 05/17/15 - 01:56 pm
ASCO
cystic fibrosis
neratinib
Puma Biotechnology
Bluebird Bio
SAGE Therapeutics
Orkambi
Vertex Pharmaceuticals
Sage Therapeutics reports 1Q loss
Yahoo/AP
Thu, 05/14/15 - 10:59 am
SAGE Therapeutics
earnings
The Coming Boom In Brain Medicines
Forbes
Wed, 02/11/15 - 09:33 am
Yumanity Therapeutics
SAGE Therapeutics
Acadia
Naurex
brain research
Biotech upstart Sage sees early efficacy for rare brain seizure drug
Fierce Biotech
Tue, 11/11/14 - 10:48 am
SAGE Therapeutics
SAGE-547
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »